Shanghai Sanyou Medical Stock Working Capital
| 688085 Stock | 22.70 0.42 1.82% |
Shanghai Sanyou Medical fundamentals help investors to digest information that contributes to Shanghai Sanyou's financial success or failures. It also enables traders to predict the movement of Shanghai Stock. The fundamental analysis module provides a way to measure Shanghai Sanyou's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shanghai Sanyou stock.
The current year's Change In Working Capital is expected to grow to about 94.4 M, whereas Net Working Capital is forecasted to decline to about 694.8 M. Shanghai | Working Capital |
Shanghai Sanyou Medical Company Working Capital Analysis
Shanghai Sanyou's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Shanghai Sanyou Working Capital | 751.85 M |
Most of Shanghai Sanyou's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shanghai Sanyou Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Shanghai Net Invested Capital
Net Invested Capital |
|
In accordance with the company's disclosures, Shanghai Sanyou Medical has a Working Capital of 751.85 M. This is 76.64% higher than that of the Health Care Equipment & Supplies sector and 44.76% lower than that of the Health Care industry. The working capital for all China stocks is 49.14% higher than that of the company.
Shanghai Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shanghai Sanyou's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Shanghai Sanyou could also be used in its relative valuation, which is a method of valuing Shanghai Sanyou by comparing valuation metrics of similar companies.Shanghai Sanyou is currently under evaluation in working capital category among its peers.
Shanghai Fundamentals
| Return On Equity | 0.0232 | ||||
| Return On Asset | 0.0103 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 4.93 B | ||||
| Shares Outstanding | 248.45 M | ||||
| Shares Owned By Insiders | 51.57 % | ||||
| Shares Owned By Institutions | 14.52 % | ||||
| Price To Book | 2.86 X | ||||
| Price To Sales | 12.94 X | ||||
| Revenue | 460.39 M | ||||
| Gross Profit | 577.77 M | ||||
| EBITDA | 67.9 M | ||||
| Net Income | 91.22 M | ||||
| Total Debt | 4.15 M | ||||
| Book Value Per Share | 7.69 X | ||||
| Cash Flow From Operations | 267.43 M | ||||
| Earnings Per Share | 0.14 X | ||||
| Number Of Employees | 466 | ||||
| Beta | -0.24 | ||||
| Market Capitalization | 5.62 B | ||||
| Total Asset | 2.26 B | ||||
| Retained Earnings | 581.46 M | ||||
| Working Capital | 751.85 M | ||||
| Net Asset | 2.26 B | ||||
| Last Dividend Paid | 0.078 |
About Shanghai Sanyou Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shanghai Sanyou Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanghai Sanyou using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanghai Sanyou Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
Shanghai Sanyou financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Sanyou security.